We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Abingdon Health Limited (ABDX) ORD GBP0.00025

Sell:9.10p Buy:9.50p 0 Change: 0.25p (2.62%)
Market closed Prices as at close on 18 September 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Miscellaneous

Abingdon Health Limited ORD GBP0.00025

Type:
Miscellaneous
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 19 Aug 2024)

What is happening?


Abingdon Health (ABDX) have announced their intention to raise up to £5.7m via a Placing (for Institutional Investors) and a Retail Offer (for Individual Investors).


Abingdon Health (ABDX) have decided not to issue a Prospectus as part of the fundraising. This means that the Retail Offer has been limited to the Sterling equivalent of €8 million and may only be open for a number of hours. It also means that information relating to the fundraising is limited to the Company announcement.

 

• Applications are due to close at 3:30pm on Wednesday 28 August. Due to the nature of the fundraising, applications can close at any time and without prior warning.


• Shares are being offered at a fixed price of 9.75 pence.


• The minimum application for the Retail Offer is £100.


• By applying for shares in the Retail Offer you are deemed to have read, understood and agreed to the HL Retail Offer Risk Warnings, Terms and Conditions and the Company Announcement.


• Hargreaves Lansdown will receive 0.6% commission from the Issuer as part of the Offer.


• The Retail Offer is capped at a maximum of £500,000, meaning that if the total value of applications received by the Issuer exceeds this figure, a scaling back policy is likely to be applied.

 

What are my options?

 

Option 1 – Do Nothing. If you do not return an election by the deadline of 3:30pm on Wednesday 28 August, the Offer will lapse.


Option 2 – You can choose to buy new Shares at 9.75 pence. If you wish to submit an order outside of the product you currently hold your shares, please leave a note in the comments section of the application.

 

When do I have to decide by?


Any instruction to participate in the Retail Offer must be received by 3:30pm on Wednesday 28 August. If no instruction is received the Offer will lapse.

 

Before submitting an instruction, you should carefully read the Company Announcement, HL Retail Offer Risk Warnings & Terms and Conditions which are attached to the Retail Offer notification. You can find this in the Secure Messaging Centre of your online account.

 

By submitting an instruction, you are deemed to have read and understood these documents as well as agreed to any terms within.

 

What happens after I apply?

 

If you apply for shares you will receive two Secure Messages. The first will confirm your application and be sent shortly after 4:30pm on Wednesday 28 August. The second will confirm how many shares you have been allocated and be sent once the results have been announced on Thursday 29 August.


You can view your application in the Pending Orders tab of your online account from 12pm on Thursday 29 August.


Your new shares will be credited shortly before 8am on Friday 30 August. This may be delayed in the event the company does not deliver your shares to us by this time.


To assist the Company during the allocation process, we may be required to disclose the number of Abingdon Health (ABDX) shares you hold with Hargreaves Lansdown. We will do this by calculating the shares held in your Hargreaves Lansdown account at the close of business on Friday 16 August.


It should be noted that a subscription for the Retail Shares and any investment in the Company carry a number of risks. Investors should make their own investigations into the merits of an investment in the Company. This message is not personal advice and is a summary of the Abingdon Health (ABDX) announcement.


If you require any assistance, please contact our Helpdesk on 0117 900 9000.

×
Sell:9.10p
Buy:9.50p
Change: 0.25p (2.62%)
Market closed Prices as at close on 18 September 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Miscellaneous

Abingdon Health Limited ORD GBP0.00025

Type:
Miscellaneous
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 19 Aug 2024)

What is happening?


Abingdon Health (ABDX) have announced their intention to raise up to £5.7m via a Placing (for Institutional Investors) and a Retail Offer (for Individual Investors).


Abingdon Health (ABDX) have decided not to issue a Prospectus as part of the fundraising. This means that the Retail Offer has been limited to the Sterling equivalent of €8 million and may only be open for a number of hours. It also means that information relating to the fundraising is limited to the Company announcement.

 

• Applications are due to close at 3:30pm on Wednesday 28 August. Due to the nature of the fundraising, applications can close at any time and without prior warning.


• Shares are being offered at a fixed price of 9.75 pence.


• The minimum application for the Retail Offer is £100.


• By applying for shares in the Retail Offer you are deemed to have read, understood and agreed to the HL Retail Offer Risk Warnings, Terms and Conditions and the Company Announcement.


• Hargreaves Lansdown will receive 0.6% commission from the Issuer as part of the Offer.


• The Retail Offer is capped at a maximum of £500,000, meaning that if the total value of applications received by the Issuer exceeds this figure, a scaling back policy is likely to be applied.

 

What are my options?

 

Option 1 – Do Nothing. If you do not return an election by the deadline of 3:30pm on Wednesday 28 August, the Offer will lapse.


Option 2 – You can choose to buy new Shares at 9.75 pence. If you wish to submit an order outside of the product you currently hold your shares, please leave a note in the comments section of the application.

 

When do I have to decide by?


Any instruction to participate in the Retail Offer must be received by 3:30pm on Wednesday 28 August. If no instruction is received the Offer will lapse.

 

Before submitting an instruction, you should carefully read the Company Announcement, HL Retail Offer Risk Warnings & Terms and Conditions which are attached to the Retail Offer notification. You can find this in the Secure Messaging Centre of your online account.

 

By submitting an instruction, you are deemed to have read and understood these documents as well as agreed to any terms within.

 

What happens after I apply?

 

If you apply for shares you will receive two Secure Messages. The first will confirm your application and be sent shortly after 4:30pm on Wednesday 28 August. The second will confirm how many shares you have been allocated and be sent once the results have been announced on Thursday 29 August.


You can view your application in the Pending Orders tab of your online account from 12pm on Thursday 29 August.


Your new shares will be credited shortly before 8am on Friday 30 August. This may be delayed in the event the company does not deliver your shares to us by this time.


To assist the Company during the allocation process, we may be required to disclose the number of Abingdon Health (ABDX) shares you hold with Hargreaves Lansdown. We will do this by calculating the shares held in your Hargreaves Lansdown account at the close of business on Friday 16 August.


It should be noted that a subscription for the Retail Shares and any investment in the Company carry a number of risks. Investors should make their own investigations into the merits of an investment in the Company. This message is not personal advice and is a summary of the Abingdon Health (ABDX) announcement.


If you require any assistance, please contact our Helpdesk on 0117 900 9000.

×
Sell:9.10p
Buy:9.50p
Change: 0.25p (2.62%)
Market closed Prices as at close on 18 September 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Miscellaneous

Abingdon Health Limited ORD GBP0.00025

Type:
Miscellaneous
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 19 Aug 2024)

What is happening?


Abingdon Health (ABDX) have announced their intention to raise up to £5.7m via a Placing (for Institutional Investors) and a Retail Offer (for Individual Investors).


Abingdon Health (ABDX) have decided not to issue a Prospectus as part of the fundraising. This means that the Retail Offer has been limited to the Sterling equivalent of €8 million and may only be open for a number of hours. It also means that information relating to the fundraising is limited to the Company announcement.

 

• Applications are due to close at 3:30pm on Wednesday 28 August. Due to the nature of the fundraising, applications can close at any time and without prior warning.


• Shares are being offered at a fixed price of 9.75 pence.


• The minimum application for the Retail Offer is £100.


• By applying for shares in the Retail Offer you are deemed to have read, understood and agreed to the HL Retail Offer Risk Warnings, Terms and Conditions and the Company Announcement.


• Hargreaves Lansdown will receive 0.6% commission from the Issuer as part of the Offer.


• The Retail Offer is capped at a maximum of £500,000, meaning that if the total value of applications received by the Issuer exceeds this figure, a scaling back policy is likely to be applied.

 

What are my options?

 

Option 1 – Do Nothing. If you do not return an election by the deadline of 3:30pm on Wednesday 28 August, the Offer will lapse.


Option 2 – You can choose to buy new Shares at 9.75 pence. If you wish to submit an order outside of the product you currently hold your shares, please leave a note in the comments section of the application.

 

When do I have to decide by?


Any instruction to participate in the Retail Offer must be received by 3:30pm on Wednesday 28 August. If no instruction is received the Offer will lapse.

 

Before submitting an instruction, you should carefully read the Company Announcement, HL Retail Offer Risk Warnings & Terms and Conditions which are attached to the Retail Offer notification. You can find this in the Secure Messaging Centre of your online account.

 

By submitting an instruction, you are deemed to have read and understood these documents as well as agreed to any terms within.

 

What happens after I apply?

 

If you apply for shares you will receive two Secure Messages. The first will confirm your application and be sent shortly after 4:30pm on Wednesday 28 August. The second will confirm how many shares you have been allocated and be sent once the results have been announced on Thursday 29 August.


You can view your application in the Pending Orders tab of your online account from 12pm on Thursday 29 August.


Your new shares will be credited shortly before 8am on Friday 30 August. This may be delayed in the event the company does not deliver your shares to us by this time.


To assist the Company during the allocation process, we may be required to disclose the number of Abingdon Health (ABDX) shares you hold with Hargreaves Lansdown. We will do this by calculating the shares held in your Hargreaves Lansdown account at the close of business on Friday 16 August.


It should be noted that a subscription for the Retail Shares and any investment in the Company carry a number of risks. Investors should make their own investigations into the merits of an investment in the Company. This message is not personal advice and is a summary of the Abingdon Health (ABDX) announcement.


If you require any assistance, please contact our Helpdesk on 0117 900 9000.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Abingdon Health plc is an international lateral flow contract research (CRO) and contract development and manufacturing organization (CDMO). The Company is engaged in offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. It focuses on supporting the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas, such as infectious disease, clinical testing including companion diagnostics, and others. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests. It also specializes in meeting compliance requirements in the international IVD and medical device markets.

Contact details

Address:
York Biotech Campus, Sand Hutton
YORK
YO41 1LZ
United Kingdom
Telephone:
+44 (01904) 406050
Website:
https://www.abingdonhealth.com/

Important dates

Future events
There are no future events available.
Past events
General meeting 12 August 2024 12/08/24
Trading Announcement 09 July 2024 09/07/24
Interim results 14 March 2024 14/03/24
Trading Announcement 11 January 2024 11/01/24
AGM 15 December 2023 15/12/23
Final results 17 October 2023 17/10/23

General stock information

EPIC:
ABDX
ISIN:
GB00BLF79J41
Market cap:
£17.63 million
Shares in issue:
189.52 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Christopher Yates
    Chief Executive Officer, Executive Director
  • Andrew Feather
    Interim Finance Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.